Biochim Biophys Acta. 2009 Jul; 1792(7) : 688-702. Epub 2008 Oct 25. Cell replacement therapy for Parkinson’s disease. Wijeyekoon R, Barker RA. Cambridge Centre for Brain Repair, Forvie Site, Cambridge, UK. Abstract Parkinson’s disease (PD) is a progressive neurodegenerative disorder in which the degeneration of dopaminergic neurons projecting from the substantia nigra to the striatum…

Cell Tissue Res. 2008 Jan; 331(1) : 301-22. Epub 2007 Sep 28. Human stem cells for CNS repair. Zietlow R, Lane EL, Dunnett SB, Rosser AE. Brain Repair Group, School of Biosciences, Cardiff University, Cardiff, CF10 3US, UK. zietlowr@cf.ac.uk Abstract Although most peripheral tissues have at least a limited ability for self-repair, the central nervous…

Neurosurg Focus. 2008; 24(3-4) : E11. Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders. Yu D, Silva GA. Department of Bioengineering, University of California, San Diego, USA. Abstract In the past decades, stem cell biology has made a profound impact on our views of mammalian development as well as…

J Neuroimmune Pharmacol. 2007 Sep; 2(3) : 243-50. Epub 2007 May 9. Stem cell transplantation: a promising therapy for Parkinson’s disease. Wang Y, Chen S, Yang D, Le WD. Institute of Health Sciences, Shanghai Institutes for Biological Sciences of Chinese Academy of Science and Shanghai Jiao Tong University School of Medicine, 225# South Chongqing Road,…

Ann Med. 2005; 37(7) : 487-98. Stem cell-based therapy for Parkinson’s disease. Correia AS, Anisimov SV, Li JY, Brundin P. Neuronal Survival Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Lund, Sweden. Sofia.Correia@med.lu.se Abstract Motor dysfunctions in Parkinson’s disease are considered to be primarily due to the degeneration of dopaminergic neurons in…

Curr Opin Neurol. 2005 Aug; 18(4) : 376-85. Stem cell treatment for Parkinson’s disease: an update for 2005. Snyder BJ, Olanow CW. Department of Neurosurgery, Mount Sinai School of Medicine, New York, NY 10029, USA. Abstract PURPOSE OF REVIEW: The hallmark pathologic feature of Parkinson’s disease is loss of melanized dopaminergic neurons within the substantia…